9926:HKG
Akeso Inc
HK$91,30
arrow_upward
+0,94%(+0,85) 1D
16 ຕ.ລ., 16 ໂມງ 8 ນາທີ 14 ວິນາທີ GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 9926...
Open
HK$92,15
High
HK$95,30
Low
HK$90,15
Mkt. cap
84,10 ຕື້
Avg. vol.
10,45 ລ້ານ
Volume
11,09 ລ້ານ
52-wk high
HK$156,00
52-wk low
HK$80,20
EPS
HK$-1,24
No. of employees
4 ພັນ
Open
HK$92,15
High
HK$95,30
Low
HK$90,15
Mkt. cap
84,10 ຕື້
Avg. vol.
10,45 ລ້ານ
Volume
11,09 ລ້ານ
52-wk high
HK$156,00
52-wk low
HK$80,20
EPS
HK$-1,24
No. of employees
4 ພັນ
News stories
From web sources and news partners
Yahoo Finance
·
20 ຊົ່ວໂມງກ່ອນ
Will Phase III Colon Cancer Trial Change Akeso Stock Narrative
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees4,08 ພັນ
Founded19 ມ.ນ. 2012
Headquarters-
SectorBiotechnology
Websiteakesobio.com